The stock has exhibited significant volatility over the past six months, with a sharp rally in late March 2026 driving the price from a low near $20 to a recent close of $23.81. Overall, the stock is down 2.74% over the last six months but has shown strong relative strength, outperforming the S&P 500 by 0.08% over that period and by 16.15% over the last month. The 1-month price change is a notable +10.90%, contrasting with a slight 3-month decline of -0.87%. The current price of $23.81 sits near the middle of its 52-week range of $11.97 to $26.44, representing a recovery from recent lows but still well below the yearly high. No RSI data was provided for a more granular momentum assessment.

Revenue in the latest quarter (Q1 2026) was $9.30 billion, showing robust year-over-year growth of 19.1%. However, profitability has been inconsistent; the net margin in Q1 2026 was a healthy 4.45%, a significant improvement from the negative margin of -13.84% in Q2 2025. The company's financial health is mixed, with a debt-to-equity ratio of 0.91 indicating moderate leverage, but a current ratio of 1.01 suggests limited liquidity headroom. Operational efficiency metrics are weak, with a trailing twelve-month Return on Equity (ROE) of just 0.23% and a Return on Assets (ROA) of 1.61%, indicating poor returns on shareholder and company assets.